rose12
Showing 1 - 1 of 1
Solid Tumor Trial in Chuo-ku (ROSE12, Atezolizumab)
Recruiting
- Solid Tumor
- ROSE12
- Atezolizumab
-
Chuo-ku, Tokyo, JapanNational Cancer Center Hospital
Jun 14, 2023